Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Tuesday, November 3, 2026

Back to today

AMD Earnings Review

AMD reported $13.4 billion in Q3 revenue, with Data Center sales up 97% to $8.5 billion, and guided Q4 revenue to $17 billion.

AMD $798B
Cestrian Capital Research 3 clicks

From X

@MaiusPartners

Maius on X

Compute and infrastructure expenses are expected to reach ~$13.0bn in Q4 as the $SPCX contract ramps. Meanwhile, revenue is expected to reach $18.6–20.3bn in Q4, up ~10–20% QoQ, with the competitive environment and holiday seasonality as potential headwinds. That puts revenue per compute dollar at ~1.5x. Meanwhile, roughly $80/$120bn of payments are against disclosed commitments in 2027/28 that help underwrite the entire global AI trade. The harder question is how quickly and profitably can API usage grow next year? Coding has been a clear winner. But sustaining growth requires either deeper usage within the industry and/or broader deployment across other high knowledge-intensive industries (finance, healthcare, legal). For the former, a ceiling is emerging, especially when sophisticated clients choose to train their own models to avoid the closed-source tax (e.g., Palantir). For the latter, those opportunities are large but much harder to capture, as turning them into reliable production systems requires data integration, domain-specific knowledge, corporate and regulatory approvals, and sometimes an entire organizational workflow redesign. Anthropic’s own $100m program to train 10,000 deployment engineers illustrates the work still required. However, wherever you look, the most sophisticated industry players choose to train their own models, e.g., Harvey AI using Kimi. Given this dynamic, it's not hard to paint a scenario where the“revenue per dollar of compute” metric continues to decline further in 2027 as industry capacity ramps, and hence one can see why the market is becoming extremely skeptical of the entire AI trade, given the labs are essentially underwriting the entire semiconductor industry at this stage. Where am I underestimating the upside: usage intensity (AGI? Humanoid Robots?), deployment speed in legacy industries? Or the entire cost curve?
@Adam_Wyden 1 click

Adam D. Wyden on X

$DRVN Full year numbers DIDNT CHANGE in our view. They mentioned restatement costs of at least $50mm and the midpoint of restatement before was 40... My guess is incremental restatement cost is 10-20.. So if the restatement is high might have even been a beat... Take 5 comp was 4.9 pct and holding two year stack in 4q would imply 8.5 pct... this seems like a kitchen sink to me. Franchise brands and auto glass both look good too.
@StableBread

Fajasy on X

Management at TOYO Co., Ltd $TOYO won’t put a number on H2 2026 beyond “positive EBITDA,” after EBITDA fell to $34.0M in Q2 from $48.1M in Q1. $TOYO’s H1 2026 results show both its earnings power and the June break: → Revenue: $261.0M, up 87.6% y/y, but Q2’s $118.2M was down 17.2% from Q1, as cell sales fell 46.4% q/q. → Gross margin: 32.5%, up from 16.6%. Q2’s 31.3% compared with 20.9% a year earlier, and the 6-K credits the increase to “increase in provision of OEM services.” → Net income: $45.8M, or $1.20/diluted share, up from $2.5M, with Q2 at $17.4M. → EBITDA: $82.1M, with $48.1M in Q1 and $34.0M in Q2. → Cash flow: $61.4M from operations, less $27.8M of capex, for $33.7M of FCF. → Volumes: 2.61 GW of cells (1.45 GW in Q1, 1.16 GW in Q2) and 191.5 MW of modules. OEM fees (for cells made under one customer’s name) rose to $25.0M in Q2 from $12.2M in Q1, while cell sales fell to $61.4M from $114.6M, and since $TOYO books those fees net, the shift lifted the margin. Inventory rose to $132.1M as of June 30 from $80.0M as of December 31, which the 6-K attributes to lower June revenue during the U.S. customs (CBP) review. $TOYO wrote down $6.5M of inventory in H1, and it ties recoverability to CBP’s final decision. $TOYO beat its 2025 revenue target but missed its net income bars for 2024 and 2025, and its 2026 targets are on hold: → 2024: Its audited net profit, excluding a $35.1M accounting gain on its earnout shares, was $5.4M against the $41M its SPAC deal required, so 11,287,703 of the 13M earnout shares were canceled in May 2025. → 2025: Raised its targets in September 2025, from 3.5 GW of cells and $33M of net income, to $375-400M of revenue, 4.2-4.4 GW of cells, and $39-45M of net income. Revenue came in at $427.4M and cells at 4.5 GW, both above the targets, but GAAP net income of $37.2M missed, while adjusted net income came to $52.2M after adding back $13.7M of stock comp and a $1.3M earnout charge. → 2026: Guided on March 31 to 5.5-5.8 GW of cells, 1.0-1.3 GW of modules, and $90-100M of adjusted net income, which CEO Takahiko Onozuka said would “nearly double net income again.” $TOYO reaffirmed it on May 18, didn’t on August 19, and gave no figures on September 28 beyond positive H2 EBITDA. H1 delivered $46.0M of adjusted net income, 51.1% of the low end of the target, plus 47.5% of the cell target and 19.2% of the module target. So $TOYO’s trailing earnings are backed by cash, but most of them came from H2 2025 and Q1 2026, before the detentions. That’s why you should expect H2 2026 EBITDA to come in below H1’s $82.1M.

Investor Letters

All letters

Stevanato down 30%. Yikes.

Stevanato fell 30% after forecasting low-single-digit 2027 growth as lower Nexa syringe volumes from a GLP-1 customer offset solid Q3…

STVN $5.4B
Best Anchor Stocks 3 clicks
BSP · short

Bending Spoons Spa

Bending Spoons is a software and digital-assets holding company that has completed more than 50 acquisitions since 2013.

BSP $29B
Value Investors Club 1 click

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 70 of 272

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

91 accounts
Nominate an account

Investor letters we follow

271 firms

Sectors

Ordered by how often our editor reaches for them.